Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Oconee Federal Financial Corp. (OFED)
|
Add to portfolio |
|
|
Price: |
$25.01
| | Metrics |
OS: |
5.61
|
M
| |
|
|
Market cap: |
$140
|
M
| |
|
|
|
|
| |
|
|
|
|
| | | |
| | | | | |
TTM Valuation | | | |
|
|
| |
|
|
|
|
| |
|
|
EPS |
| |
|
|
BVPS
|
$13.12
| |
1.91
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Jun-30-22 | Jun-30-21 | Jun-30-20 | Jun-30-19 | Jun-30-18 | Jun-30-17 | Jun-30-16 | Jun-30-15 |
Revenues | 17.0 | 16.9 | 16.8 | 16.7 | 16.8 | 17.8 | 18.8 | 16.2 |
Revenue growth | 0.7% | 0.3% | 0.5% | -0.4% | -5.4% | -5.4% | 16.1% | 28.1% |
Cost of goods sold | 8.7 | 8.4 | 8.4 | 8.7 | 8.3 | 7.8 | 7.8 | 6.3 |
Gross profit | 8.3 | 8.4 | 8.4 | 8.1 | 8.5 | 10.0 | 10.9 | 9.8 |
Gross margin | 48.7% | 49.9% | 50.2% | 48.2% | 50.7% | 56.3% | 58.3% | 60.8% |
Sales and marketing | 0.3 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
Research and development | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 | 0.7 | 0.5 | 0.4 |
General and administrative | 0.6 | 0.7 | 0.8 | 0.8 | 1.2 | 1.0 | 0.2 | 1.1 |
EBITA | 6.4 | 6.5 | 6.6 | 6.2 | 6.2 | 8.2 | 9.1 | 8.5 |
EBITA margin | 37.6% | 38.9% | 39.0% | 37.3% | 37.0% | 46.2% | 48.5% | 52.6% |
Amortization of intangibles | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.0 | 0.1 |
EBIT | 6.3 | 6.5 | 6.5 | 6.1 | 6.1 | 8.1 | 9.1 | 8.4 |
EBIT margin | 37.2% | 38.4% | 38.5% | 36.6% | 36.1% | 45.5% | 48.3% | 52.1% |
Pre-tax income | 5.1 | 5.1 | 4.8 | 4.6 | 4.7 | 7.0 | 7.3 | 7.2 |
Income taxes | 1.0 | 1.1 | 0.9 | 0.9 | 1.7 | 1.5 | 2.0 | 2.7 |
Tax rate | 19.2% | 20.7% | 18.9% | 19.0% | 36.0% | 21.1% | 27.9% | 37.4% |
Net income | 4.1 | 4.1 | 3.9 | 3.7 | 3.0 | 5.5 | 5.2 | 4.5 |
Net margin | 24.2% | 24.1% | 23.0% | 22.2% | 18.1% | 31.1% | 28.0% | 27.9% |
|
Diluted EPS | $0.73 | $0.72 | $0.68 | $0.65 | $0.52 | $0.96 | $0.91 | $0.79 |
Shares outstanding (diluted) | 5.6 | 5.6 | 5.7 | 5.8 | 5.8 | 5.8 | 5.8 | 5.7 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|